Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (18) , 2329-2334
- https://doi.org/10.1016/s0959-8049(00)00341-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- Single-Agent Paclitaxel in the Treatment of Advanced Non-Small Cell Lung CancerThe Oncologist, 1999
- Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trialEuropean Journal Of Cancer, 1999
- Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancerBritish Journal of Cancer, 1999
- Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancerAnnals of Oncology, 1999
- Gemcitabine: Single-Agent and Combination Therapy in Non-Small Cell Lung CancerThe Oncologist, 1999
- Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaCancer, 1999
- Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II TrialJournal of Clinical Oncology, 1999
- Pulmonary Infiltrates Following Administration of PaclitaxelChest, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995